![Michael Grissinger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Grissinger
Directeur/Membre du Conseil chez
APREA THERAPEUTICS, INC.
Fortune : 1 791 $ au 31/07/2026
Profil
Michael Grissinger is currently Chairman at Kira Biotech Pty Ltd. since 2020, Director at Atrin Pharmaceuticals LLC since 2018, Independent Director at Aprea Therapeutics, Inc. since 2022, Director at Atriva Therapeutics GmbH since 2020, Director at Envisagenics, Inc., Independent Director at Adicet Bio, Inc. starting 2025, Director at NephroDI Therapeutics, Inc., Director at AnaCardio AB, and Independent Director at Lipocine, Inc. starting 2026.
Former roles include Independent Director at resTORbio, Inc. from 2018 to 2020, Director at Atrin Pharmaceuticals, Inc., Independent Director at Akari Therapeutics Plc from 2018 to 2024, Member-Management Board at Janssen Pharmaceuticals, Inc., and VP & Head-Pharmaceutical Corporate Development at Johnson & Johnson.
Education includes an undergraduate degree from Juniata College and an MBA from Fox School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/06/2026 | 2 889 ( 0,02% ) | 1 791 $ | 31/07/2026 | |
ADICET BIO INC -.--% | 21/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Postes actifs de Michael Grissinger
| Sociétés | Poste | Début |
|---|---|---|
| APREA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/05/2022 |
| ADICET BIO, INC. | Directeur/Membre du Conseil | 17/04/2025 |
| LIPOCINE INC. | Directeur/Membre du Conseil | 03/08/2026 |
Atrin Pharmaceuticals LLC
 Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Engages in discovery and development of proprietary medications | Directeur/Membre du Conseil | 01/11/2018 |
Kira Biotech Pty Ltd.
 Kira Biotech Pty Ltd. BiotechnologyHealth Technology Operates as biotechnology company which develops novel immunomodulatory compounds for the treatment of immune system disorders | Président | 30/07/2020 |
Atriva Therapeutics GmbH
 Atriva Therapeutics GmbH BiotechnologyHealth Technology Develops anti-tumour medicine | Directeur/Membre du Conseil | 01/12/2020 |
Envisagenics, Inc.
 Envisagenics, Inc. BiotechnologyHealth Technology Operates biotechnology company that provides artificial intelligence and RNA-splicing analytics for discovery & development of disease specific therapeutics | Directeur/Membre du Conseil | - |
AnaCardio AB
 AnaCardio AB Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops novel drugs to treat heart failure | Directeur/Membre du Conseil | - |
Nephrodi Therapeutics, Inc.
 Nephrodi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel AMPK activators for kidney diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Michael Grissinger
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░ ░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Michael Grissinger
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
58
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Juniata College
 Juniata College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lipocine, Inc.
 Lipocine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in research and development for the delivery of drugs | Health Technology |
Fox School of Business
 Fox School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atrin Pharmaceuticals LLC
Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Engages in discovery and development of proprietary medications | Health Technology |
Akari Therapeutics Plc
 Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Develops anti-tumour medicine | Health Technology |
Envisagenics, Inc.
Envisagenics, Inc. BiotechnologyHealth Technology Operates biotechnology company that provides artificial intelligence and RNA-splicing analytics for discovery & development of disease specific therapeutics | Health Technology |
resTORbio, Inc.
 resTORbio, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Aprea Therapeutics, Inc.
 Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
Kira Biotech Pty Ltd.
Kira Biotech Pty Ltd. BiotechnologyHealth Technology Operates as biotechnology company which develops novel immunomodulatory compounds for the treatment of immune system disorders | Health Technology |
Adicet Bio, Inc.
 Adicet Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development of cell immunotherapies | Health Technology |
Nephrodi Therapeutics, Inc.
Nephrodi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel AMPK activators for kidney diseases | Health Technology |
AnaCardio AB
AnaCardio AB Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops novel drugs to treat heart failure | Commercial Services |
Atrin Pharmaceuticals, Inc.
 Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Health Technology |
